Research articleChronic cerebral hypoperfusion upregulates leptin receptor expression in astrocytes and tau phosphorylation in tau transgenic mice
Introduction
Alzheimer’s disease (AD) is the most common type of dementia and involves progressive deterioration of memory and other cognitive domains. AD is pathologically characterized by neurofibrillary tangles and amyloid plaques composed of phosphorylated tau and amyloid β (Aβ) peptides, respectively, as well as the loss of neurons, amyloid angiopathy, and vascular lesions [1]. Reports that hemodynamic deficits and brain ischemia can affect AD pathology indicate that vascular pathology plays a critical role in the pathogenesis of AD [2]; indeed, chronic cerebral hypoperfusion per se induces not only white matter lesions, but also hippocampal atrophy in association with dementia [3].
Epidemiological studies have revealed a correlation between mid-life obesity and cognitive decline [4,5]. High body weight and obesity are risk factors for not only cerebrovascular diseases but also and AD [5]. Obesity reportedly aggravates ischemic damage [6] and upregulates leptin signaling and tau phosphorylation [7,8]. Leptin is a fat cell-derived hormone that regulates weight and fat stores through its action in the hypothalamus, and leptin deficiency can cause obesity [9,10]. Leptin further fulfills multiple other roles, including immune function, bone metabolism, and neurogenesis, axon growth, and synaptogenesis [11]. Leptin receptor (leptin-R) is expressed constitutively in the cerebral cortex and hippocampus and is involved in learning and memory [12]. As leptin can deactivate GSK-3β via the phosphorylation of Ser-9 and the resultant downregulation of tau phosphorylation, leptin dysfunction may contribute to AD pathology [13].
Leptin-R is upregulated in the peri-infarct cortices during acute cerebral ischemia [6], which indicates its potential neurotrophic and neuroprotective activity against ischemic insults. However, there is a dearth of information on the role of leptin signaling in chronic cerebral hypoperfusion. We therefore examined changes in leptin-R and tau phosphorylation across chronic cerebral hypoperfusion using transgenic (Tg) mice that overexpress human tau. The results of this study suggest that chronic cerebral hypoperfusion increases leptin-R expression in astrocytes and augments tau phosphorylation.
Section snippets
Animal model
The present study used 10 8-month-old male tau (T44) Tg mice overexpressing the shortest human tau isoform [14]. Mice were anesthetized with isoflurane in a 70% N2O/30% O2 mixture. In five mice, we placed a microcoil (diameter: 0.18 mm; Samini Co. Ltd., Shizuoka, Japan) in the bilateral common carotid artery to generate a bilateral common carotid artery stenosis (BCAS) model as reported previously [15,16]. The remaining five mice underwent sham surgery, during which common carotid arteries of
Results
We investigated the effect of chronic cerebral hypoperfusion on the brain using tau Tg mouse (T44) and the possible mechanism of leptin-R induction in primary astrocyte cultures. Moreover, we confirmed the pathological findings in human postmortem brain.
Discussion
The present study demonstrated that chronic cerebral hypoperfusion promotes tau phosphorylation and upregulates leptin-R in the brain of tau Tg mice. Several lines of evidences have shown that chronic cerebral hypoperfusion and hypoxia are involved in the pathogenesis of AD. Long-term hypoxia can causes an increase of Aβ deposition, neuritic plaque formation, and memory deficits in the brains of amyloid precursor protein (APP) Tg mice, another murine model of AD [21,22]. In addition, a recent
Conclusion
This study demonstrated that chronic cerebral hypoperfusion increased leptin-R expression and tau phosphorylation. We also provided evidence for the association between leptin signaling and AD pathology through the PI3K/AKT pathway. Leptin thus demonstrates potential as therapeutic target to treat not only ischemic stroke but also AD.
Competing interests
The authors declare that they have no competing interests.
Ethics approval and consent to participate
All studies were performed according to protocols approved by the Mie University Ethical Committee on Research Animal Care in accordance with the National Institutes of Health Guide for the Care, and Use of Laboratory Animals (permit number 665 and 28-19), and the Medical Ethics Committees of Mie University Hospital (permit number 1523).
Author’s contributions
Conceived and designed the experiences: TS, AS, and HT.
Performed experiments: TS, AS, and HM.
Analyzed the data: TS, and AS
Contributed reagents/materials/analysis tools: KY, RS, AN, TA, TM, and HW.
Wrote the paper: TS, AS, HM, KY, RS, AN, TA, TM, HW, and HT.
Acknowledgements
We gratefully acknowledge Prof. Ryosuke Takahashi (Department of Neurology, Kyoto University Graduate School of Medicine) for collaboration on the autopsy brain study performed in this work, as well as Kaori Kawamura (department of Neurology, Mie University Hospital, Tsu, Japan) for her technical help. This study was supported in part by KAKENHI (Japan Society of Promotion of Science, Tokyo) Grant Number 18K16557.
References (36)
Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression
Neurobiol. Dis.
(2014)Immunohistochemical analysis of tau phosphorylation and astroglial activation with enhanced leptin receptor expression in diet-induced obesity mouse hippocampus
Neurosci. Lett.
(2014)Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives
Cell Metab.
(2013)Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
Neuron
(1999)Cilostazol alleviates white matter degeneration caused by chronic cerebral hypoperfusion in mice: implication of its mechanism from gene expression analysis
Neurosci. Lett.
(2018)Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation
J. Biol. Chem.
(2007)Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice
Brain Res.
(2009)Oligemic hypoperfusion differentially affects tau and amyloid-{beta}
Am. J. Pathol.
(2010)Leptin reduces Alzheimer’s disease-related tau phosphorylation in neuronal cells
Biochem. Biophys. Res. Commun.
(2008)Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization
FEBS Lett.
(1996)
Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology
Biochim. Biophys. Acta
Leptin exerts proliferative and anti-apoptotic effects on goose granulosa cells through the PI3K/Akt/mTOR signaling pathway
J. Steroid Biochem. Mol. Biol.
Alzheimer’s disease
N. Engl. J. Med.
Atherosclerosis of cerebral arteries in Alzheimer disease
Stroke
Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes
J. Aging Res.
Central obesity and increased risk of dementia more than three decades later
Neurology
Midlife overweight and obesity increase late-life dementia risk: a population-based twin study
Neurology
Inflammatory and injury responses to ischemic stroke in obese mice
Stroke
Cited by (14)
Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia
2023, Experimental NeurologyHonokiol prevents chronic cerebral hypoperfusion induced astrocyte A1 polarization to alleviate neurotoxicity by targeting SIRT3-STAT3 axis
2023, Free Radical Biology and MedicineExtracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation
2022, Journal of Vascular SurgeryCitation Excerpt :Positron emission tomography-based studies of humans have found decreased cerebral perfusion associated with higher tau depositions in the entorhinal cortex, independent of Aβ pathology.30 In addition, animal-based studies have demonstrated that decreased cerebral perfusion is associated with increased tau phosphorylation without affecting the amyloid pathology in the hippocampus and cortex.31,32 These findings correlated with our results, which suggest specificity of ECAD association with NFT accumulation and raises the hypothesis that the hypoperfusion associated with ECAD might contribute to NFT accumulation.
Association of Tooth Loss with Alzheimer’s Disease Tau Pathologies Assessed by Positron Emission Tomography
2023, Journal of Alzheimer's DiseaseA brief overview of a mouse model of cerebral hypoperfusion by bilateral carotid artery stenosis
2023, Journal of Cerebral Blood Flow and MetabolismGray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease
2023, Journal of Cerebral Blood Flow and Metabolism